MEDI.F Stock Overview
A pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
MediPharm Labs Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.05 |
| 52 Week High | CA$0.075 |
| 52 Week Low | CA$0.037 |
| Beta | 0.92 |
| 11 Month Change | -14.66% |
| 3 Month Change | -0.20% |
| 1 Year Change | 7.61% |
| 33 Year Change | -71.21% |
| 5 Year Change | -98.28% |
| Change since IPO | -97.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDI.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -3.0% | 1.6% | 2.2% |
| 1Y | 7.6% | 9.9% | 31.6% |
Return vs Industry: MEDI.F underperformed the US Pharmaceuticals industry which returned 10% over the past year.
Return vs Market: MEDI.F underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| MEDI.F volatility | |
|---|---|
| MEDI.F Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MEDI.F has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MEDI.F's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 166 | David Pidduck | www.medipharmlabs.com |
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products.
MediPharm Labs Corp. Fundamentals Summary
| MEDI.F fundamental statistics | |
|---|---|
| Market cap | US$19.12m |
| Earnings (TTM) | -US$8.41m |
| Revenue (TTM) | US$27.94m |
0.7x
P/S Ratio-2.3x
P/E RatioIs MEDI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDI.F income statement (TTM) | |
|---|---|
| Revenue | CA$39.05m |
| Cost of Revenue | CA$25.34m |
| Gross Profit | CA$13.71m |
| Other Expenses | CA$25.46m |
| Earnings | -CA$11.75m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.029 |
| Gross Margin | 35.10% |
| Net Profit Margin | -30.10% |
| Debt/Equity Ratio | 1.3% |
How did MEDI.F perform over the long term?
See historical performance and comparison